News

Shares of Aurora Cannabis Inc. ACB shed 2.58% to $4.15 Friday, on what proved to be an all-around positive trading session ...
Shares of Aurora Cannabis Inc. ACB rose 8.67% to $4.26 Thursday, on what proved to be an all-around great trading session for ...
Aurora Cannabis (NASDAQ:ACB) traded higher on Thursday after the company expanded the eligibility for its compassionate ...
Aurora Cannabis has expanded its compassionate pricing program for medical marijuana patients in Canada, increasing the ...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest ...
Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 ...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis ...
For all the ways Colorado’s cannabis ... Brooks hopes to partner with dispensaries that offer delivery so customers in Denver and Aurora ... “Rosin has a very strong terpene profile ...
Aurora Cannabis (NASDAQ:ACB – Get Free Report) is projected to announce its earnings results before the market opens on Thursday, February 13th.
Aurora Cannabis reported FQ3 revenues of C$88 million, up only C$7 million from the prior quarter. The big key to the quarter was the drastic improvement in adjusted EBITDA and free cash flows.
Aurora Cannabis introduces new products, including CBD Varius and premium sativa strains for veterans. Recent innovations include ultra-high-potency indicas with THC levels of up to 31%.
Cannabis giant Tilray Brands, Inc. TLRY announced the latest small batch indica strain by its craft cannabis brand, ... Aurora vs. Canopy & Tilray: ... Rich terpene profile featuring: Limonene ...